Sunbelt Securities’s AnaptysBio ANAB Stock Holding History

Sunbelt Securities’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222	Hold	4	–	–	﹤0.01%	2488
2025 Q4	$194	Hold	4	–	–	﹤0.01%	2437
2025 Q3	$122	Buy	+4	New	+$92	﹤0.01%	2484

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sunbelt Securities's ANAB Position: Q1 2026 in Review

Sunbelt Securities held its AnaptysBio (ANAB) position steady in Q1 2026 at 4 shares worth $222. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Sunbelt Securities first reported a position in ANAB in Q3 2025 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Sunbelt Securities held 4 shares of AnaptysBio worth $222 as of Q1 2026.
Sunbelt Securities left its AnaptysBio share count unchanged in Q1 2026.
AnaptysBio made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2488 holding.
Sunbelt Securities first reported a position in AnaptysBio in Q3 2025 and has held it in 3 quarters since.
208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.